Spyre Therapeutics, Inc. — SC 13G/A Filings
61 SC 13G/A filings on record
This page lists all SC 13G/A filings submitted to the SEC by Spyre Therapeutics, Inc. (SYRE), sorted by most recent first. Each row links to the full filing on EdgarLookup. Spyre Therapeutics, Inc. has filed 61 SC 13G/A documents with the SEC since 2015. To view all SEC filings by Spyre Therapeutics, Inc., see the full filings list.
All
10-K
10-K/A
10-Q
10-Q/A
144
3
3/A
4
4/A
424B3
424B4
424B5
5
8-A12B
8-K
8-K/A
ARS
CERTNAS
CORRESP
CT ORDER
D
DEF 14A
DEFA14A
DRS
EFFECT
FWP
POS AM
PRE 14A
PRER14A
S-1
S-1/A
S-3
S-3/A
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| SC 13G/A | SC 13G/A | 0001104659-24-119333 | Nov 14, 2024 | — |
| SC 13G/A | SC 13G/A | 0001193125-24-258682 | Nov 14, 2024 | — |
| SC 13G/A | — | 0001493152-24-045810 | Nov 14, 2024 | — |
| SC 13G/A | — | 0001172661-24-004773 | Nov 14, 2024 | — |
| SC 13G/A | SPYRE THERAPEUTICS, INC. | 0000902664-24-006526 | Nov 14, 2024 | — |
| SC 13G/A | — | 0000315066-24-002912 | Nov 12, 2024 | — |
| SC 13G/A | — | 0000315066-24-001784 | Jun 10, 2024 | — |
| SC 13G/A | SPYRE THERAPEUTICS INC. | 0000902664-24-003035 | Apr 23, 2024 | — |
| SC 13G/A | — | 0000315066-24-001673 | Mar 11, 2024 | — |
| SC 13G/A | SC 13G/A | 0001104659-24-024226 | Feb 14, 2024 | — |
| SC 13G/A | SC 13G/A | 0001104659-24-023876 | Feb 14, 2024 | — |
| SC 13G/A | — | 0000935836-24-000203 | Feb 14, 2024 | — |
| SC 13G/A | SC 13G/A | 0001193125-24-036324 | Feb 14, 2024 | — |
| SC 13G/A | SC 13G/A | 0001104659-24-023722 | Feb 14, 2024 | — |
| SC 13G/A | — | 0001493152-24-006628 | Feb 14, 2024 | — |
| SC 13G/A | — | 0000935836-24-000193 | Feb 14, 2024 | — |
| SC 13G/A | — | 0001172661-24-001205 | Feb 14, 2024 | — |
| SC 13G/A | — | 0001172661-24-000943 | Feb 14, 2024 | — |
| SC 13G/A | SC 13G/A | 0001193125-24-034079 | Feb 13, 2024 | — |
| SC 13G/A | — | 0000919574-24-001081 | Feb 13, 2024 | — |
| SC 13G/A | AMENDMENT TO FORM SC 13G | 0001999371-24-002149 | Feb 13, 2024 | — |
| SC 13G/A | — | 0001172661-24-000761 | Feb 13, 2024 | — |
| SC 13G/A | — | 0000315066-24-001638 | Feb 12, 2024 | — |
| SC 13G/A | — | 0001319244-24-000024 | Feb 8, 2024 | — |
| SC 13G/A | SC 13G/A | 0001104659-23-021874 | Feb 14, 2023 | — |
| SC 13G/A | AMENDMENT NO. 6 | 0000947871-23-000163 | Feb 14, 2023 | — |
| SC 13G/A | SC 13G/A | 0001193125-23-036871 | Feb 14, 2023 | — |
| SC 13G/A | — | 0000919574-23-000935 | Feb 13, 2023 | — |
| SC 13G/A | — | 0001319244-23-000001 | Jan 10, 2023 | — |
| SC 13G/A | SCHEDULE 13G (AMENDMENT #2) | 0000899140-22-000301 | Feb 14, 2022 | — |
| SC 13G/A | SC 13G/A | 0001193125-22-039215 | Feb 14, 2022 | — |
| SC 13G/A | AMENDMENT NO. 5 | 0000947871-22-000192 | Feb 11, 2022 | — |
| SC 13G/A | AEGLEA BIOTHERAPEUTICS, INC. | 0000902664-22-001333 | Feb 10, 2022 | — |
| SC 13G/A | — | 0000834237-22-006253 | Feb 3, 2022 | — |
| SC 13G/A | SCHEDULE 13G/A | 0001104659-21-024310 | Feb 16, 2021 | — |
| SC 13G/A | SCHEDULE 13G (AMENDMENT #1) | 0000899140-21-000287 | Feb 16, 2021 | — |
| SC 13G/A | SCHEDULE 13G/A | 0001104659-21-023286 | Feb 16, 2021 | — |
| SC 13G/A | AMENDMENT NO. 4 | 0000947871-21-000167 | Feb 12, 2021 | — |
| SC 13G/A | AEGLEA BIOTHERAPEUTICS, INC. | 0000902664-21-001115 | Feb 11, 2021 | — |
| SC 13G/A | SC 13G/A | 0001104659-21-017002 | Feb 10, 2021 | — |
| SC 13G/A | — | 0000834237-20-009474 | May 8, 2020 | — |
| SC 13G/A | SC 13G/A | 0001104659-20-021749 | Feb 14, 2020 | — |
| SC 13G/A | — | 0001172661-20-000648 | Feb 14, 2020 | — |
| SC 13G/A | SCHEDULE 13G/A | 0001104659-20-020224 | Feb 13, 2020 | — |
| SC 13G/A | SC 13G/A | 0001104659-20-020194 | Feb 13, 2020 | — |
| SC 13G/A | AEGLEA BIOTHERAPEUTICS, INC. | 0000902664-20-000951 | Feb 12, 2020 | — |
| SC 13G/A | — | 0000834237-20-004706 | Feb 5, 2020 | — |
| SC 13G/A | 13G AMENDED ANNUAL FILING (AGLE) | 0000053417-20-000005 | Feb 3, 2020 | — |
| SC 13G/A | SC 13G/A | 0001104659-20-008697 | Jan 30, 2020 | — |
| SC 13G/A | SC 13G/A | 0001144204-19-008123 | Feb 14, 2019 | — |